Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: AAREYDRUGS and BSE: 524412 (ISIN INE198H01019).
It has a market capitalisation of ₹324 crore, a last close of ₹113.87 on 2026-10-19, a one-year return of 29.5%.
Valuation: a price-to-earnings ratio of 77.62x, a price-to-book ratio of 2.15x, a dividend yield of 0.0%.
Profitability: return on equity of 2.7%, return on capital employed of 7.1%, an operating margin of 1.6%.
Growth: sales growth of -8.9% a year over three years, net profit growth of -7.1% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.33x, promoter holding of 41.5%.
| Metric | Value |
|---|---|
| Market capitalisation | 324 |
| Last close | ₹113.87 |
| P/E (TTM) | 77.62x |
| P/B | 2.15x |
| Dividend yield | 0.0% |
| ROE (FY) | 2.7% |
| ROCE (FY) | 7.1% |
| Operating margin (TTM) | 1.6% |
| Sales growth, 3-year CAGR | -8.9% |
| Profit growth, 3-year CAGR | -7.1% |
| Debt / equity | 0.33x |
| Promoter holding | 41.5% |
| 1-year return | 29.5% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means